Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
Hopkins
Michael M
MM
Martin
Paul A
PA
D002491:Central Nervous System Agents / Q000627:therapeutic use*; D015195:Drug Design; D020022:Genetic Predisposition to Disease / Q000235:genetics / Q000517:prevention & control; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy* / Q000235:genetics; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000235:genetics; D010597:Pharmacogenetics / Q000639:trends*; D010818:Practice Patterns, Physicians' / Q000639:trends; D011320:Primary Health Care / Q000639:trends*
D002491:Central Nervous System Agents